Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0NL7J
|
|||
| Former ID |
DNC013214
|
|||
| Drug Name |
N1-(4-chlorobenzyl)-2-amino-N3-hydroxymalonamide
|
|||
| Synonyms |
CHEMBL385996
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H12ClN3O3
|
|||
| Canonical SMILES |
C1=CC(=CC=C1CNC(=O)C(C(=O)NO)N)Cl
|
|||
| InChI |
1S/C10H12ClN3O3/c11-7-3-1-6(2-4-7)5-13-9(15)8(12)10(16)14-17/h1-4,8,17H,5,12H2,(H,13,15)(H,14,16)
|
|||
| InChIKey |
OGTJYIPAKYEFNR-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Aminopeptidase N (ANPEP) | Target Info | Inhibitor | [1] |
| BioCyc | Glutathione-mediated detoxification | |||
| KEGG Pathway | Glutathione metabolism | |||
| Metabolic pathways | ||||
| Renin-angiotensin system | ||||
| Hematopoietic cell lineage | ||||
| Pathwhiz Pathway | Glutathione Metabolism | |||
| Pathway Interaction Database | C-MYB transcription factor network | |||
| Reactome | Metabolism of Angiotensinogen to Angiotensins | |||
| WikiPathways | Metabolism of Angiotensinogen to Angiotensins | |||
| Cardiac Progenitor Differentiation | ||||
| miR-targeted genes in squamous cell - TarBase | ||||
| miR-targeted genes in muscle cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | ||||
| miR-targeted genes in leukocytes - TarBase | ||||
| Glutathione metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents. J Med Chem. 2007 Mar 22;50(6):1322-34. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.